Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase subunit 6C pseudogene 4 (COX6CP4)
- Target
- COX6CP4
- Molecular classification
- Pseudogene, Noncoding RNA (potential)
01
Overview
Cytochrome c oxidase subunit 6C pseudogene 4 (COX6CP4) is a member of the pseudogene family related to the *cytochrome c oxidase* (complex IV of the mitochondrial electron transport chain) subunit 6C. As a pseudogene, COX6CP4 does not encode a functional protein product due to the accumulation of disabling mutations such as stop codons, frameshifts, or incomplete open reading frames[2]. Pseudogenes like COX6CP4 may sometimes be transcribed into noncoding RNAs, which in other cases have been shown to participate in the regulation of their parent genes or have tissue-specific expression patterns, but there is no evidence of COX6CP4 having a specific biological or disease-related function[1][2]. Pseudogenes often introduce confusion in gene annotation databases but may serve roles as regulatory RNAs in selected contexts.
- Other names
- COX6CP4Cytochrome c oxidase subunit VIc pseudogene 4
02
Mechanism of action
Not applicable for drugs, as the pseudogene does not encode a functional protein target.
03
Biological functions
No known canonical protein functionMay have potential regulatory roles at the RNA level, such as contributing to regulation of its parent gene or related pathways via noncoding transcripts, including possible microRNA decoy activity or RNA interference pathways
04
Disease associations
No direct disease association established for COX6CP4 itselfIn general, some pseudogenes have been implicated as regulators in cancer or other diseases due to their role as competitive endogenous RNAs or microRNA decoys
05
Safety considerations
Not applicable; as a non-coding pseudogene, there are no direct therapeutic safety concerns.
06
Interacting drugs
None known; as a pseudogene, COX6CP4 does not produce a protein target for drug interaction.
07
Biomarkers
None established for COX6CP4In general, some pseudogene transcripts may be used as biomarkers if their expression is altered in disease, but this is not reported for COX6CP4
Beyond the preview
Go deeper on Cytochrome c oxidase subunit 6C pseudogene 4 (COX6CP4).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cytochrome c oxidase subunit 6C pseudogene 4 (COX6CP4).